Hester Biosciences Limited (NSE:HESTERBIO)

Market Cap	17.67B
Revenue (ttm)	3.15B
Net Income (ttm)	375.94M
Shares Out	n/a
EPS (ttm)	43.07
PE Ratio	47.00
Forward PE	n/a
Dividend	7.00 (0.33%)
Ex-Dividend Date	Aug 6, 2025

Volume	3,374
Average Volume	7,828
Open	2,124.10
Previous Close	2,117.70
Day's Range	2,073.40 - 2,125.00
52-Week Range	1,242.95 - 2,786.10
Beta	0.12
RSI	55.22
Earnings Date	Nov 14, 2025

About Hester Biosciences

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella abortus, lumpy skin disease, contagio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 562
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HESTERBIO

Financial Performance

In 2024, Hester Biosciences's revenue was 3.12 billion, an increase of 0.41% compared to the previous year's 3.11 billion. Earnings were 274.88 million, an increase of 45.52%.